Prostaglandin F2alpha Antikörper
Reaktivität: Hormone
IF (p), ELISA, IHC (fro), IHC (p)
Wirt: Kaninchen
Polyclonal
unconjugated
-
- Target Alle Prostaglandin F2alpha Antikörper anzeigen
- Prostaglandin F2alpha
-
Reaktivität
- Hormone
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Prostaglandin F2alpha Antikörper ist unkonjugiert
- Applikation
- Immunofluorescence (Paraffin-embedded Sections) (IF (p)), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität
- Ratte
- Kreuzreaktivität (Details)
- PGF2 Alpha
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated to PGF2 Alpha
- Isotyp
- IgG
-
-
- Applikationshinweise
-
IHC-P 1:100-500
IF(IHC-P) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- Prostaglandin F2alpha
- Andere Bezeichnung
- Pgf2 alpha (Prostaglandin F2alpha Produkte)
- Substanzklasse
- Hormone
- Hintergrund
-
Synonyms: Prostaglandin F2 Alpha, PGF2 Alpha, 5Z,9,11,13E,15S-9,11,15-Trihydroxyprosta-5,13-dienoic acid tris salt, PGF2−,Tris.
Background: Luteolytic prostaglandin that induces parturition. Potent vasoconstrictor of pulmonary, coronary, and cerebral arteriole beds. A positive feedback loop between endometrial PG F2 and luteal oxytocin is responsible for completion of luteolysis.Luteolytic prostaglandin that induces parturition. Potent vasoconstrictor of pulmonary, coronary, and cerebral arteriole beds. Also stimulates contraction of smooth muscle, such as in bronchi, with possible involvement in asthma. This effect is at least partially mediated through tachykinin release.
-
Sie sind hier:
